Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 265

1.

TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.

Lyu C, Bing SJ, Wandu WS, Xu B, Shi G, Hinshaw SJ, Lobera M, Caspi RR, Lu L, Yang J, Gery I.

Eur J Immunol. 2018 Sep 15. doi: 10.1002/eji.201747029. [Epub ahead of print]

PMID:
30218573
2.

The Phenotype of Monocytes in Anterior Uveitis Depends on the HLA-B27 Status.

Kasper M, Walscheid K, Laffer B, Bauer D, Busch M, Wildschütz L, Wang B, Loser K, Vogl T, Grajewski RS, Langmann T, Heiligenhaus A.

Front Immunol. 2018 Jul 30;9:1773. doi: 10.3389/fimmu.2018.01773. eCollection 2018.

3.

Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis.

Liang D, Shao H, Born WK, O'Brien RL, Kaplan HJ, Sun D.

Crit Rev Immunol. 2018;38(3):233-243. doi: 10.1615/CritRevImmunol.2018026150.

PMID:
30004859
4.
5.

Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Puccetti A, Fiore PF, Pelosi A, Tinazzi E, Patuzzo G, Argentino G, Moretta F, Lunardi C, Dolcino M.

J Immunol Res. 2018 Apr 24;2018:4246965. doi: 10.1155/2018/4246965. eCollection 2018.

6.

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.

Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Arsenijevic N, Volarevic V.

Adv Exp Med Biol. 2018 May 18. doi: 10.1007/5584_2018_219. [Epub ahead of print]

PMID:
29774506
7.

Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.

Gilbert RM, Zhang X, Sampson RD, Ehrenstein MR, Nguyen DX, Chaudhry M, Mein C, Mahmud N, Galatowicz G, Tomkins-Netzer O, Calder VL, Lightman S.

Front Immunol. 2018 May 3;9:907. doi: 10.3389/fimmu.2018.00907. eCollection 2018.

8.

Increased Circulating Proinflammatory T Lymphocytes in Children with Different Forms of Anterior Uveitis: Results from a Pilot Study.

Walscheid K, Neekamp L, Heiligenhaus A, Weinhage T, Heinz C, Foell D.

Ocul Immunol Inflamm. 2018 May 17:1-10. doi: 10.1080/09273948.2018.1467464. [Epub ahead of print]

PMID:
29771573
9.

Immune Profiling of T Cells Infiltrating Vitreous Humor in Tubercular Uveitis.

Sharma RK M.Sc, Gupta V M.S, Bansal R M.S, Sharma K M.D, Gupta A M.S, Sachdeva N Ph.D.

Immunol Invest. 2018 Aug;47(6):615-631. doi: 10.1080/08820139.2018.1470640. Epub 2018 May 7.

PMID:
29733740
10.

Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.

He Y, Wang C, Su G, Deng B, Ye Z, Huang Y, Yuan G, Aize K, Li H, Yang P.

Br J Ophthalmol. 2018 Aug;102(8):1167-1172. doi: 10.1136/bjophthalmol-2017-311707. Epub 2018 Apr 26.

PMID:
29699987
11.

Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis.

Kumar B, Cashman SM, Kumar-Singh R.

Mol Ther. 2018 Jun 6;26(6):1568-1580. doi: 10.1016/j.ymthe.2018.03.012. Epub 2018 Mar 19.

PMID:
29678656
12.

Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.

Xiong T, Li X, Zhou Y, Song Q, Zhang R, Lei L, Li X.

Acta Biomater. 2018 Jun;73:275-284. doi: 10.1016/j.actbio.2018.04.019. Epub 2018 Apr 13.

PMID:
29660509
13.

Baicalin modulates the Treg/Teff balance to alleviate uveitis by activating the aryl hydrocarbon receptor.

Zhu W, Chen X, Yu J, Xiao Y, Li Y, Wan S, Su W, Liang D.

Biochem Pharmacol. 2018 Aug;154:18-27. doi: 10.1016/j.bcp.2018.04.006. Epub 2018 Apr 13.

PMID:
29656117
14.

Behçet's disease: New insights into pathophysiology, clinical features and treatment options.

Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, de Vincentiis M, Lambiase A.

Autoimmun Rev. 2018 Jun;17(6):567-575. doi: 10.1016/j.autrev.2017.12.006. Epub 2018 Apr 6. Review.

PMID:
29631062
15.

Local S100A8 Levels Correlate With Recurrence of Experimental Autoimmune Uveitis and Promote Pathogenic T Cell Activity.

Yun J, Xiao T, Zhou L, Beuerman RW, Li J, Zhao Y, Hadayer A, Zhang X, Sun D, Kaplan HJ, Shao H.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1332-1342. doi: 10.1167/iovs.17-23127.

16.

Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis.

Takeda A, Yamada H, Hasegawa E, Arima M, Notomi S, Myojin S, Yoshimura T, Hisatomi T, Enaida H, Yanai R, Kimura K, Ishibashi T, Sonoda KH.

Jpn J Ophthalmol. 2018 May;62(3):398-406. doi: 10.1007/s10384-018-0587-4. Epub 2018 Mar 23.

PMID:
29572578
17.

Cytokines in uveitis.

Weinstein JE, Pepple KL.

Curr Opin Ophthalmol. 2018 May;29(3):267-274. doi: 10.1097/ICU.0000000000000466. Review.

PMID:
29521875
18.

Immunohistochemical characterization of feline lymphoplasmacytic anterior uveitis.

Crossfield L, Fortuna L, Carling R, Scurrell E, Matas Riera M, Chang YM, Dawson C, Pittaway R, Yeung IY, Thaung C, Priestnall SL, Garden OA.

Vet Ophthalmol. 2018 Mar 8. doi: 10.1111/vop.12569. [Epub ahead of print]

PMID:
29517855
19.

Effect of Adalimumab on Peripheral Blood Mononuclear Cells in Non-Infectious Uveitis.

Walscheid K, Weinhage T, Foell D, Heinz C, Kasper M, Heiligenhaus A.

Ocul Immunol Inflamm. 2017 Oct 11:1-8. doi: 10.1080/09273948.2017.1374415. [Epub ahead of print]

PMID:
29020495
20.

IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.

Dambuza IM, He C, Choi JK, Yu CR, Wang R, Mattapallil MJ, Wingfield PT, Caspi RR, Egwuagu CE.

Nat Commun. 2017 Sep 28;8(1):719. doi: 10.1038/s41467-017-00838-4.

Supplemental Content

Loading ...
Support Center